Suzuki M, Sekiguchi I, Tamada T, Tsuru S
Department of Obstetrics and Gynecology, School of Medicine, Jichi Medical School, Tochigi, Japan.
Oncology. 1991;48(6):474-9. doi: 10.1159/000226984.
The protective effects of elastase (Ela) and fosfomycin against renal toxicity of cis-diamminedichloroplatinum (II) (CDDP) were evaluated in an experimental study using rats. When Ela was used concomitantly with CDDP, the elevation of urinary N-acetyl-beta-D-glucosaminidase levels in the early phase and the sharp fall in these levels in the latter phase were prevented. It was also found that the blood urea nitrogen levels and serum creatinine levels were significantly lowered. Histologically, atrophic and necrotic changes in the tubular epithelium were prevented. The total serum platinum levels showed no change with the addition of Ela; however, the platinum levels in the renal tissues were significantly reduced. These results suggested that Ela is effective against platinum deposits in the renal tissues, particularly in the tubular epithelium, thus protecting the kidneys. On the other hand, fosfomycin demonstrated no such positive results suggestive of a protective effect on the renal function parameters or during histological observation.
在一项使用大鼠的实验研究中,评估了弹性蛋白酶(Ela)和磷霉素对顺二氨二氯铂(II)(CDDP)肾毒性的保护作用。当Ela与CDDP同时使用时,可预防早期尿N-乙酰-β-D-氨基葡萄糖苷酶水平的升高以及后期这些水平的急剧下降。还发现血尿素氮水平和血清肌酐水平显著降低。组织学上,肾小管上皮的萎缩和坏死性改变得到预防。添加Ela后总血清铂水平无变化;然而,肾组织中的铂水平显著降低。这些结果表明,Ela对肾组织尤其是肾小管上皮中的铂沉积有效,从而保护肾脏。另一方面,磷霉素未显示出对肾功能参数或组织学观察有保护作用的此类阳性结果。